May 17, 2022

Jennifer Byrne Named One of the 2022 PM360 ELITE 100

WINSTON-SALEM, N.C., May 16, 2022 – PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, has named Jennifer Byrne, Founder and CEO, Javara as one of the 2022 PM360 ELITE 100 in the Entrepreneur category. Now in its eighth year, the PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represents the most influential people in the healthcare industry today.   

 A thought leader in the clinical research space, Jennifer Byrne is driving revolutionary change across the industry – for patients, biopharma companies and healthcare systems alike. Her passion and commitment to transforming the clinical research landscape into an integrated component of healthcare are at the forefront of Javara’s mission. Jennifer’s career has been devoted to leading and building teams to cultivate partnerships centered on advancing the clinical research enterprise to better connect patients and providers to clinical trials. 

 “It’s an honor to be recognized alongside such innovative and influential leaders in healthcare,” said Jennifer Byrne, CEO, Javara. “When founded, the vision for Javara was to build a company that would improve the health and lives of people by improving patients access to research. Four years later, we are now reaching more than 5 million patients and 5,800 providers and growing, all to bring the hope of clinical research participation closer to home. It is a privilege to work alongside pioneers across biopharma and the medical device industry and beyond to affect real change in the lives of others.” 

 The PM360 ELITE Awards were established in 2015 to recognize individuals and teams who have made a significant impact on the life sciences and healthcare industries throughout their careers. More than 500 submissions were received, and nominees were evaluated and selected by the PM360 editorial staff based on their accomplishments; testimonials from their bosses, clients, and colleagues; and supporting evidence that reflects the impact of their efforts. A total of 100 winners were selected across 20 categories, including Creative Directors, Data Miners, Digital Crusaders, Drug Researchers and Developers, Entrepreneurs, Environmental Champions, Philanthropic Heroes, Strategists, Transformational Leaders and more. 

 “Our industry accomplished great things during the pandemic to ensure people could be protected against COVID, treated for it, and still access all of the other medications they need, but this disruption to our world also revealed ways in which our industry could be even better,” says Anna Stashower, CEO and Publisher of PM360. “Many of this year’s winners sprang into action to improve areas the pandemic exposed as needing changes, including addressing health equity, social determinants of health, clinical research, patient access and affordability, and much more. That’s what makes them the most influential people our industry has to offer—their ability to push the industry forward to make healthcare better for all.” 

 The winners were profiled in PM360’s May 2022 issue. You can read their profiles online at https://www.pm360online.com/the-2022-pm360-elite-100.     

 Additionally, the 2022 ELITE 100 will be celebrated at the annual ELITE Awards Event, which will be held at 230 FIFTH in New York City on July 13th starting at 7 PM EST. A special keynote address from Uber ELITE Winner Mikael Dolsten, MD, PhD, Chief Scientific Officer and President, Worldwide Research, Development, and Medical, Pfizer Inc., will kick-off the celebration.  

 Tickets for the event can be purchased at https://www.pm360online.com/elitetickets. 


#  #  # 


About PM360 


PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment. 

 The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read. 

 By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game. 


About Javara 

Javara, the leading Integrated Research Organization (IRO), partners with large healthcare organizations to deliver clinical trial access at the point of care, reaching patients through their trusted physician by integrating research staff and infrastructure. Our broad diverse patient populations ensure clinical trials are completed with high enrollment and retention for quality data delivery. Javara’s centralized resources and standardized operations provide efficiencies for accelerated study start-up and quality outcomes, so fewer obstacles stand in the way of the product approval process. As pioneers of Clinical Research as a Care Option (CRAACO), Javara is transforming healthcare and changing lives through a reimagined approach to clinical trials. For more information, please visit javararesearch.com. 


Javara Media Contact:
Shannon Severino